We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,482 results
  1. Pharmacological characterization of P2Y receptor subtypes – an update

    P2Y receptors are G-protein-coupled receptors (GPCRs) for extracellular nucleotides. There are eight mammalian P2Y receptor subtypes (P2Y 1 , P2Y 2 , P2Y 4 ...

    Ivar von Kügelgen in Purinergic Signalling
    Article Open access 12 September 2023
  2. Therapeutic potential for P2Y2 receptor antagonism

    G protein-coupled receptors are the target of more than 30% of all FDA-approved drug therapies. Though the purinergic P2 receptors have been an...

    Kimberly J. Jasmer, Kevin Muñoz Forti, ... Gary A. Weisman in Purinergic Signalling
    Article 11 October 2022
  3. P2Y11/IL-1 receptor crosstalk controls macrophage inflammation: a novel target for anti-inflammatory strategies?

    Although first cloning of the human ATP receptor P2Y 11 was successful 25 years ago, the exact downstream signaling pathways of P2Y 11 receptor, which...

    Dominik Klaver, Martin Thurnher in Purinergic Signalling
    Article Open access 05 April 2023
  4. Machine learning-aided search for ligands of P2Y6 and other P2Y receptors

    The P2Y 6 receptor, activated by uridine diphosphate (UDP), is a target for antagonists in inflammatory, neurodegenerative, and metabolic disorders,...

    Ana C. Puhl, Sarah A. Lewicki, ... Kenneth A. Jacobson in Purinergic Signalling
    Article Open access 25 March 2024
  5. Transactivation of receptor tyrosine kinases by purinergic P2Y and adenosine receptors

    Transactivation of receptor tyrosine kinases (RTK) is a crosstalk mechanism exhibited by G-protein–coupled receptors (GPCR) to activate signaling...

    F. G. Vázquez-Cuevas, M. Reyna-Jeldes, ... C. Coddou in Purinergic Signalling
    Article 19 December 2022
  6. Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists

    Pulmonary vascular tone is modulated by nucleotides, but which P2 receptors mediate these actions is largely unclear. The aim of this study,...

    Markie O. Dales, Callum Mitchell, ... Charles Kennedy in Purinergic Signalling
    Article Open access 26 August 2022
  7. Tumoral P2Y2 receptor modulates tumor growth and host anti-tumor immune responses in a syngeneic murine model of oral cancer

    Head and neck squamous cell carcinomas (HNSCCs) are a heterogenous group of tumors and among the top 10 most common cancers and they arise from the...

    Kevin Muñoz Forti, Lucas T. Woods, ... Gary A. Weisman in Purinergic Signalling
    Article 12 August 2023
  8. LncRNA-UC.25 + shRNA Alleviates P2Y14 Receptor–Mediated Diabetic Neuropathic Pain via STAT1

    Diabetic neuropathic pain (DNP) is a common complication of diabetes, and its complicated pathogenesis, as well as clinical manifestations, has...

    Baoguo Wu, Congfa Zhou, ... Guilin Li in Molecular Neurobiology
    Article 22 June 2022
  9. P2Y12 receptor antagonism inhibits proliferation, migration and leads to autophagy of glioblastoma cells

    Glioblastoma (GBM) is the most aggressive and lethal among the primary brain tumors, with a low survival rate and resistance to radio and...

    Pedro Vargas, Thamiris Becker Scheffel, ... Fernanda Bueno Morrone in Purinergic Signalling
    Article 08 August 2022
  10. Genetic polymorphisms of purinergic P2Y2 receptor were associated with the susceptibility to essential hypertension in Chinese postmenopausal women

    Hypertension has become a prominent public health concern. Essential hypertension (EH) is a polygenic disorder caused by multiple susceptibility...

    Ao Li, Chaopeng **ong, ... Hong Xu in Purinergic Signalling
    Article 19 January 2023
  11. Purinergic inhibitory regulation of esophageal smooth muscle is mediated by P2Y receptors and ATP-dependent potassium channels in rats

    Purines such as ATP are regulatory transmitters in motility of the gastrointestinal tract. The aims of this study were to propose functional roles of...

    Takahiko Shiina, Yuji Suzuki, ... Yasutake Shimizu in The Journal of Physiological Sciences
    Article Open access 23 April 2024
  12. How selective antagonists and genetic modification have helped characterise the expression and functions of vascular P2Y receptors

    Vascular P2Y receptors mediate many effects, but the role of individual subtypes is often unclear. Here we discuss how subtype-selective antagonists...

    Markie O. Dales, Robert M. Drummond, Charles Kennedy in Purinergic Signalling
    Article Open access 13 May 2024
  13. Crosstalk between P2Y receptors and cyclooxygenase activity in inflammation and tissue repair

    The role of extracellular nucleotides as modulators of inflammation and cell stress is well established. One of the main actions of these molecules...

    Adrián Povo-Retana, Sergio Sánchez-García, ... Lisardo Boscá in Purinergic Signalling
    Article Open access 13 April 2023
  14. Development of Purinergic Receptor Agonists and Antagonists

    Adenosine, P2Y, and P2X receptors have been the focus of purinergic ligand development in the pharmaceutical sector and academic medicinal chemistry...
    Chapter 2023
  15. Daidzein attenuated paclitaxel-induced neuropathic pain via the down-regulation of TRPV1/P2Y and up-regulation of Nrf2/HO-1 signaling

    Paclitaxel (PTX) is an anti-microtubule agent, used for the treatment of various types of cancers; however, it produces painful neuropathy which...

    Sana Zafar, Yong Luo, ... Salman Khan in Inflammopharmacology
    Article 05 May 2023
  16. Recommended tool compounds and drugs for blocking P2X and P2Y receptors

    This review article presents a collection of tool compounds that selectively block and are recommended for studying P2Y and P2X receptor subtypes,...

    Christa E. Müller, Vigneshwaran Namasivayam in Purinergic Signalling
    Article Open access 02 September 2021
  17. Inflammatory neuronal loss in the substantia nigra induced by systemic lipopolysaccharide is prevented by knockout of the P2Y6 receptor in mice

    Inflammation may contribute to multiple brain pathologies. One cause of inflammation is lipopolysaccharide/endotoxin (LPS), the levels of which are...

    Stefan Milde, Francesca W. van Tartwijk, ... Guy C. Brown in Journal of Neuroinflammation
    Article Open access 11 October 2021
  18. Nucleotide P2Y1 receptor agonists are in vitro and in vivo prodrugs of A1/A3 adenosine receptor agonists: implications for roles of P2Y1 and A1/A3 receptors in physiology and pathology

    Rapid phosphoester hydrolysis of endogenous purine and pyrimidine nucleotides has challenged the characterization of the role of P2 receptors in...

    Theodore E. Liston, Sonja Hinz, ... James D. Lechleiter in Purinergic Signalling
    Article 31 October 2020
  19. P2X7 and P2Y1 receptors in DRG mediate electroacupuncture to inhibit peripheral sensitization in rats with IBS visceral pain

    Although multiple purinergic receptors mediate the analgesic effects of acupuncture, it remains unclear whether there is mutual interaction between...

    Tingting Lv, Guona Li, ... Zhijun Weng in Purinergic Signalling
    Article 26 June 2024
Did you find what you were looking for? Share feedback.